INDICE: Preface xv .Acknowledgments xxi .Part I The Dynamics of Neurological Disease 1 .1 The Dynamics of Neurological Disease: Current Views and Key Issues 3 .1.1 Introduction 4 .1.2 The Complexity of Human Neurological Diseases 4 .1.3 The Nervous System as an Archetypical Complex System 9 .1.4 CNS Signaling Failures: Implications for Neurological Disease 14 .1.5 History and Key Characteristics of the Age–Dependent Neurological Diseases 14 .1.6 The Fractal Nature of Complexity in the CNS 16 .Endnotes 17 .2 Clinical and Economic Features of Age–Related Neurological Diseases 19 .2.1 Introduction 19 .2.2 Parkinson s Disease 19 .2.3 Amyotrophic Lateral Sclerosis 29 .2.4 Alzheimer s Disease 40 .2.5 Summary of the Data on the Progressive, Age–Related Neurological Diseases 47 .2.6 Neural Loci and Mechanisms of Action 48 .Endnote 49 .3 Spectrums of Neurological Disease, Clusters, and Ubiquity 51 .3.1 Introduction 51 .3.2 Spectrums of Neurological Disease 51 .3.3 The Dimension of the Problem when Assessing Potential Causal Factors in Neurological Diseases 54 .3.4 Neurological Disease Clusters 57 .3.5 Ubiquity 60 .3.6 Nested Complex Systems: Proximal versus Distal Events as They May Relate to Neurological Diseases 60 .3.7 The Path to Curing Neurological Diseases 63 .4 Complexity, Cascading Failures, and Neurological Diseases 67 .4.1 Introduction 67 .4.2 Introduction to ComplexityTheory and Complex Systems 67 .4.3 Computer Programs and Computer Crashes 69 .4.4 Biosemiosis in the CNS (Part 1) 70 .4.5 Complexity in the CNS and the Impact of Genetic and Environmental Insults 73 .4.6 Tipping Points and Time Lines of Disease Progression 77 .5 Genetic Determinants of Neurological Disease 79 .5.1 Introduction 80 .5.2 Causality versus Coincidence 80 .5.3 Actions of Mutant Genes in Neurological Disease 82 .5.4 Genetic Mutations Linked to Parkinson s Disease 84 .5.5 GeneticMutations Linked to ALS 86 .5.6 GeneticMutations Linked to Alzheimer s Disease 92 .5.7 Genes and Neurological Disease: Some General Considerations 94 .6 Environmental Determinants of Neurological Disease and Gene Toxin Interactions 97 .6.1 Introduction 98 .6.2 Toxins and Neurological Diseases 98 .6.3 Aluminum and Neurological Disease 101 .6.4 Single– vs. Multiple–Hit Models of Neurological Disease: Gene Toxin Interactions 114 .6.5 Genetic Susceptibility Factors 117 .6.6 Biosemiosis (Part 2) 123 .6.7 Gene Toxin Interactions and Cascading Failures 124 .6.8 Genes and Toxins in Neurological Disease: PenultimateThoughts 124 .6.9 And, Finally, the Microbiome 125 .Endnote 125 .7 The Mystery and Lessons of ALS–PDC 127 .7.1 Introduction 127 .7.2 Neurological Disease Clusters and ALS–PDC 128 .7.3 History and Features of ALS–PDC 129 .7.4 Cycad and ALS–PDC 135 .7.5 Amino Acid Toxins in Cycad and ALS–PDC 140 .7.6 Non–Amino Acid Toxins Linked to ALS–PDC 143 .7.7 Aluminum and Ionic Etiologies for ALS–PDC 147 .7.8 Still Other Molecules Causal to ALS–PDC 148 .7.9 What is the Current View on the Importance of ALS–PDC? 148 .7.10 Complexity of Neurological Diseases as Viewed from Guam 151 .Endnote 151 .Part II Age and Time Lines of Neurological Disease 153 .8 Neurological Disease Models and their Discontents: Validity, Replicability, and the Decline Effect 155 .8.1 Introduction 155 .8.2 Modeling Human Neurological Diseases: Possibilities and Pitfalls 156 .8.3 Considerations Regarding Model Systems 158 .8.4 Model Systems and their Discontents 159 .8.5 IsThere an Ideal Model for Studying Neurological Diseases? General Considerations 168 .8.6 Specific Considerations for Ideal Model–System Approaches in ALS 170 .8.7 Alternative Views of Neurological Disease and Model–Systems Approaches: Multiple–Hit Etiologies 172 .9 The Progression and the Time Line of Neurological Disease 175 .9.1 Introduction 175 .9.2 Creating Disease Time Lines: The Framingham Study 176 .9.3 Time Lines of Neurological Disease 176 .9.4 Back to a Multiple–Hit Disease Consideration 180 .9.5 Haecceity and Quiddity in Context to Biosemiosis and Multiple Hits 181 .9.6 Some Final Thoughts on Time Lines of Neurological Disease: Differentiation and Neurogenesis 182 .Endnote 183 .10 Development, Aging, and Neurological Disease 185 .10.1 Introduction 185 .10.2 The Fetal Basis of Adult Disease Hypothesis 186 .10.3 ASD as a Developmental Neurological Disorder 188 .10.4 Toxins and Developmental CNS Disorders 193 .10.5 Developmental versus Mature CNS Disorders 193 .Endnotes 194 .Part III Interactions and Synergies in Neurological Disease 195 .11 CNS Immune SystemInteractions and Autoimmunity 197 .11.1 Introduction 198 .11.2 Immunity and the CNS, an Introduction to a Complex Topic 198 .11.3 CNS Immune System Interactions:More Detailed Considerations 202 .11.4 Autoimmunity 205 .11.5 Immune System Signaling Errors and Autoimmunity in ASD and Other Neurological Disorders 208 .11.6 Laterality and Autoimmunity in Neurological Diseases 212 .11.7 Other System Disorders in Neurological Diseases: More Evidence for Autoimmunity? 215 .11.8 Are There Infectious Disease Links to Neurological Diseases? 215 .12 The Impact of Synergy of Factors in Neurological Disease 219 .12.1 Introduction 219 .12.2 Synergistic and Additive Effects in General and as Applied to CNS Diseases 219 .12.3 Gene Environment (Toxin) Interactions in Non–neuronal Systems 221 .12.4 Gene Environment (Toxin) Interactions in Neurological Disease 224 .12.5 Levels of Complexity in Gene Toxin Interactions: Implications for Current and FutureTherapeutics 226 .Part IV Transition and Politics in Neurological Disease 229 .13 The Current Status of Neurological Disease Treatments 231 .13.1 Introduction 231 .13.2 Current Therapeutic Approaches to Treating Neurological Diseases 232 .13.3 Summary 242 .Endnote 243 .14 The Future of Translational Research in Neurological Disease 245 .14.1 Introduction 245 .14.2 Comparing Traumatic Brain Injury to Neurological Diseases 246 .14.3 ALS and Polio: Comparing the Nature of Neural Degeneration and Progression in the Two Diseases 249 .14.4 Neurological Diseases as Spectrum Disorders: Implications for Therapy 252 .14.5 Cystic Fibrosis and Gene Therapy 254 .14.6 Restoring CNS Function: What Is the Bottom Line? 255 .14.7 Biosemiosis (Part 3) and True Narrative Representations 255 .15 Defining the Limits for Neurological Disease Treatments 259 .15.1 Introduction 259 .15.2 The Complexity of the Human CNS versus One View of the Philosophy of Science 260 .15.3 Examples of Unique Individuality: From Pilgrimages to Nature 261 .15.4 TherapeuticWindows for the Treatment of Neurological Diseases 266 .Endnotes 270 .16 The Politics and Economics of Neurological Disease 271 .16.1 Introduction 271 .16.2 The Problems with Single–Hit Models of Neurological Disease 272 .16.3 Summarizing the Main Themes by Chapter 274 .16.4 Can the Amount of Money Spent Change these Outcomes for Neurological Disease Treatment? 276 .16.5 General Considerations for the Future of Neurological Disease Research 280 .16.6 The Advent of Modern Dentistry and Dental Prophylaxis 284 .16.7 Addressing Neurological Diseases at the Individual and Population Levels 286 .Endnotes 290 .Glossary 291 .References 301 .Index 355
- ISBN: 978-1-118-63457-8
- Editorial: Wiley–Blackwell
- Encuadernacion: Cartoné
- Páginas: 408
- Fecha Publicación: 21/03/2017
- Nº Volúmenes: 1
- Idioma: Inglés